164 related articles for article (PubMed ID: 31532712)
21. Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay.
Hashimoto M; Girardi E; Eichner R; Superti-Furga G
ACS Chem Biol; 2018 Jun; 13(6):1480-1486. PubMed ID: 29851333
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Anticancer Activity of AZD3965: A Systematic Review.
Silva A; Antunes B; Batista A; Pinto-Ribeiro F; Baltazar F; Afonso J
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011413
[TBL] [Abstract][Full Text] [Related]
23. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.
Guan X; Morris ME
AAPS J; 2020 Jun; 22(4):84. PubMed ID: 32529599
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.
Noble RA; Bell N; Blair H; Sikka A; Thomas H; Phillips N; Nakjang S; Miwa S; Crossland R; Rand V; Televantou D; Long A; Keun HC; Bacon CM; Bomken S; Critchlow SE; Wedge SR
Haematologica; 2017 Jul; 102(7):1247-1257. PubMed ID: 28385782
[TBL] [Abstract][Full Text] [Related]
25. Involvement of monocarboxylate transporter 1 (SLC16A1) in the uptake of l-lactate in human astrocytes.
Ideno M; Kobayashi M; Sasaki S; Futagi Y; Narumi K; Furugen A; Iseki K
Life Sci; 2018 Jan; 192():110-114. PubMed ID: 29154783
[TBL] [Abstract][Full Text] [Related]
26. Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1).
Puri S; Stefan K; Khan SL; Pahnke J; Stefan SM; Juvale K
J Med Chem; 2023 Jan; 66(1):657-676. PubMed ID: 36584238
[TBL] [Abstract][Full Text] [Related]
27. Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration.
Beloueche-Babari M; Casals Galobart T; Delgado-Goni T; Wantuch S; Parkes HG; Tandy D; Harker JA; Leach MO
Br J Cancer; 2020 Mar; 122(6):895-903. PubMed ID: 31937921
[TBL] [Abstract][Full Text] [Related]
28. Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.
Guile SD; Bantick JR; Cheshire DR; Cooper ME; Davis AM; Donald DK; Evans R; Eyssade C; Ferguson DD; Hill S; Hutchinson R; Ingall AH; Kingston LP; Martin I; Martin BP; Mohammed RT; Murray C; Perry MW; Reynolds RH; Thorne PV; Wilkinson DJ; Withnall J
Bioorg Med Chem Lett; 2006 Apr; 16(8):2260-5. PubMed ID: 16455256
[TBL] [Abstract][Full Text] [Related]
29. [Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro].
Li QX; Zhang P; Liu F; Wang XZ; Li L; Wang ZK; Jiang CC; Zheng HL; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):588-593. PubMed ID: 28539279
[TBL] [Abstract][Full Text] [Related]
30. Cysteine 159 delineates a hinge region of the alternating access monocarboxylate transporter 1 and is targeted by cysteine-modifying inhibitors.
Köpnick AL; Geistlinger K; Beitz E
FEBS J; 2021 Oct; 288(20):6052-6062. PubMed ID: 33999492
[TBL] [Abstract][Full Text] [Related]
31. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
Khan A; Valli E; Lam H; Scott DA; Murray J; Hanssen KM; Eden G; Gamble LD; Pandher R; Flemming CL; Allan S; Osterman AL; Haber M; Norris MD; Fletcher JI; Yu DMT
Oncogene; 2020 Apr; 39(17):3555-3570. PubMed ID: 32123312
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional Spiky Topological Nanocapsules for the Discrimination and Differential Inhibition of Inflammation and Cancer.
Zhang Y; Li J; Zhang S; Li W; Ouyang J; Na N
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25727-25737. PubMed ID: 34048646
[TBL] [Abstract][Full Text] [Related]
33. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Gurrapu S; Jonnalagadda SK; Alam MA; Ronayne CT; Nelson GL; Solano LN; Lueth EA; Drewes LR; Mereddy VR
Bioorg Med Chem Lett; 2016 Jul; 26(14):3282-3286. PubMed ID: 27241692
[TBL] [Abstract][Full Text] [Related]
34. Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter.
Payen VL; Hsu MY; Rädecke KS; Wyart E; Vazeille T; Bouzin C; Porporato PE; Sonveaux P
Cancer Res; 2017 Oct; 77(20):5591-5601. PubMed ID: 28827372
[TBL] [Abstract][Full Text] [Related]
35. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
Nancolas B; Sessions RB; Halestrap AP
Biochem J; 2015 Feb; 466(1):177-88. PubMed ID: 25437897
[TBL] [Abstract][Full Text] [Related]
36. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
Galić S; Schneider HP; Bröer A; Deitmer JW; Bröer S
Biochem J; 2003 Dec; 376(Pt 2):413-22. PubMed ID: 12946269
[TBL] [Abstract][Full Text] [Related]
37. LPS-induced monocarboxylate transporter-1 inhibition facilitates lactate accumulation triggering epithelial-mesenchymal transformation and pulmonary fibrosis.
Feng J; Zhong H; Mei S; Tang R; Zhou Y; Xing S; Gao Y; Xu Q; He Z
Cell Mol Life Sci; 2024 May; 81(1):206. PubMed ID: 38709307
[TBL] [Abstract][Full Text] [Related]
38. Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters.
Gan L; Xiu R; Ren P; Yue M; Su H; Guo G; Xiao D; Yu J; Jiang H; Liu H; Hu G; Qing G
Oncogene; 2016 Jun; 35(23):3037-48. PubMed ID: 26434591
[TBL] [Abstract][Full Text] [Related]
39. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
Majumdar S; Gunda S; Pal D; Mitra AK
Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
[TBL] [Abstract][Full Text] [Related]
40. Characterization of monocarboxylate transporter 1 (MCT1) binding affinity for Basigin gene products and L1cam.
Howard J; Finch NA; Ochrietor JD
Cell Mol Neurobiol; 2010 Jul; 30(5):671-4. PubMed ID: 20155396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
